S&P 500   3,318.21 (-1.16%)
DOW   27,671.93 (-0.82%)
QQQ   267.04 (-1.21%)
AAPL   107.84 (-2.27%)
MSFT   200.10 (-1.38%)
FB   252.91 (-0.75%)
GOOGL   1,440.58 (-3.12%)
AMZN   2,940.05 (-2.28%)
NVDA   489.75 (-1.76%)
TSLA   448.28 (+5.87%)
BABA   273.69 (-0.74%)
CGC   16.32 (-0.49%)
GE   6.91 (-1.99%)
MU   50.88 (-0.20%)
AMD   75.20 (-1.76%)
T   28.94 (-0.45%)
F   7.25 (-0.41%)
ACB   6.44 (-6.53%)
GILD   65.06 (+0.03%)
NFLX   465.85 (-0.93%)
DIS   129.36 (-0.66%)
BAC   25.38 (+0.12%)
BA   162.49 (-3.01%)
S&P 500   3,318.21 (-1.16%)
DOW   27,671.93 (-0.82%)
QQQ   267.04 (-1.21%)
AAPL   107.84 (-2.27%)
MSFT   200.10 (-1.38%)
FB   252.91 (-0.75%)
GOOGL   1,440.58 (-3.12%)
AMZN   2,940.05 (-2.28%)
NVDA   489.75 (-1.76%)
TSLA   448.28 (+5.87%)
BABA   273.69 (-0.74%)
CGC   16.32 (-0.49%)
GE   6.91 (-1.99%)
MU   50.88 (-0.20%)
AMD   75.20 (-1.76%)
T   28.94 (-0.45%)
F   7.25 (-0.41%)
ACB   6.44 (-6.53%)
GILD   65.06 (+0.03%)
NFLX   465.85 (-0.93%)
DIS   129.36 (-0.66%)
BAC   25.38 (+0.12%)
BA   162.49 (-3.01%)
S&P 500   3,318.21 (-1.16%)
DOW   27,671.93 (-0.82%)
QQQ   267.04 (-1.21%)
AAPL   107.84 (-2.27%)
MSFT   200.10 (-1.38%)
FB   252.91 (-0.75%)
GOOGL   1,440.58 (-3.12%)
AMZN   2,940.05 (-2.28%)
NVDA   489.75 (-1.76%)
TSLA   448.28 (+5.87%)
BABA   273.69 (-0.74%)
CGC   16.32 (-0.49%)
GE   6.91 (-1.99%)
MU   50.88 (-0.20%)
AMD   75.20 (-1.76%)
T   28.94 (-0.45%)
F   7.25 (-0.41%)
ACB   6.44 (-6.53%)
GILD   65.06 (+0.03%)
NFLX   465.85 (-0.93%)
DIS   129.36 (-0.66%)
BAC   25.38 (+0.12%)
BA   162.49 (-3.01%)
S&P 500   3,318.21 (-1.16%)
DOW   27,671.93 (-0.82%)
QQQ   267.04 (-1.21%)
AAPL   107.84 (-2.27%)
MSFT   200.10 (-1.38%)
FB   252.91 (-0.75%)
GOOGL   1,440.58 (-3.12%)
AMZN   2,940.05 (-2.28%)
NVDA   489.75 (-1.76%)
TSLA   448.28 (+5.87%)
BABA   273.69 (-0.74%)
CGC   16.32 (-0.49%)
GE   6.91 (-1.99%)
MU   50.88 (-0.20%)
AMD   75.20 (-1.76%)
T   28.94 (-0.45%)
F   7.25 (-0.41%)
ACB   6.44 (-6.53%)
GILD   65.06 (+0.03%)
NFLX   465.85 (-0.93%)
DIS   129.36 (-0.66%)
BAC   25.38 (+0.12%)
BA   162.49 (-3.01%)
Log in
NASDAQ:RYTM

Rhythm Pharmaceuticals SEC Filings & 10K Form

$27.84
-0.62 (-2.18 %)
(As of 09/18/2020 03:39 PM ET)
Add
Compare
Today's Range
$27.35
Now: $27.84
$28.90
50-Day Range
$18.13
MA: $23.19
$30.61
52-Week Range
$12.99
Now: $27.84
$32.24
Volume8,231 shs
Average Volume249,348 shs
Market Capitalization$1.23 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.18

SEC Filings

Rhythm Pharmaceuticals (NASDAQ:RYTM) SEC Filings

DateFilerForm TypeView
09/01/2020
3:05 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
2:16 PM
Rhythm Pharmaceuticals (Filer)
Form CT ORDER
08/13/2020
3:05 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2020
8:53 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2020
4:16 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
4:16 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
4:15 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:35 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
5:31 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Rhythm Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
2:27 PM
MPM BIOVENTURES V, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
06/25/2020
4:38 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:28 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
4:26 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:08 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
5:39 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
4:14 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:48 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:59 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:28 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
10:58 AM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
05/04/2020
7:51 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEFA14A
04/29/2020
4:28 PM
Rhythm Pharmaceuticals (Filer)
Form DEF 14A
04/24/2020
2:39 PM
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
04/01/2020
3:20 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
5:00 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
3:58 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:51 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
3:48 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/02/2020
3:30 PM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2020
3:24 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:24 PM
Kelner Simon (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:23 PM
Rhythm Pharmaceuticals (Issuer)
Stewart Murray (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:23 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
3:41 PM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
7:45 AM
BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
02/05/2020
2:49 PM
MPM BIOVENTURES V, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13D/A
01/28/2020
8:57 AM
Rhythm Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/10/2020
7:46 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
3:00 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2019
3:02 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:25 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:13 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
7:05 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2019
1:40 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
3:22 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
4:30 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
8:28 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
3:22 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
7:38 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2019
4:04 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
10/18/2019
3:48 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2019
4:27 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
4:25 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
10/15/2019
3:52 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
3:51 PM
Rhythm Pharmaceuticals (Filer)
Form 424B5
09/25/2019
7:30 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
6:54 AM
Flynn James E (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
08/13/2019
3:04 PM
Desikan Nithya (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
8:07 AM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:42 PM
Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2019
3:40 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:40 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:06 PM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2019
3:01 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:11 PM
Gottesdiener Keith Michael (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:01 PM
Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:17 PM
Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:15 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:14 PM
MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:14 PM
Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:13 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:13 PM
JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:12 PM
GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2019
3:10 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
3:00 PM
Rhythm Pharmaceuticals (Issuer)
Van der Ploeg Leonardus H.T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
3:01 PM
Rhythm Pharmaceuticals (Issuer)
Van der Ploeg Leonardus H.T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
3:01 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
4:08 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
9:02 AM
Rhythm Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
3:01 PM
Rhythm Pharmaceuticals (Filer)
Form DEF 14A
03/28/2019
3:00 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2019
3:25 PM
Gottesdiener Keith Michael (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
3:01 PM
Gottesdiener Keith Michael (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:04 PM
Rhythm Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
8:56 AM
Rhythm Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:01 PM
Gottesdiener Keith Michael (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:01 PM
Gottesdiener Keith Michael (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
3:07 PM
Kelner Simon (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:14 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
02/13/2019
4:22 PM
PFIZER INC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
3:06 PM
Rhythm Pharmaceuticals (Subject)
THIRD ROCK VENTURES LP (Filed by)
Form SC 13G/A
02/13/2019
3:03 PM
Rhythm Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/12/2019
4:11 PM
JANUS HENDERSON GROUP PLC (Filed by)
Rhythm Pharmaceuticals (Subject)
Form SC 13G
02/11/2019
12:23 PM
Foley Todd (Reporting)
Rhythm Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.